TY  - RPRT
TI  - PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells.
AU  - I Martin-Kleiner
AU  - I Svoboda-Beusan
AU  - J Gabrilovac
PY  - 2006
DO  - 10.1080/08923970600927520
UR  - https://pubmed.ncbi.nlm.nih.gov/16997790/
ID  - 16997790
ER  -